🇺🇸 FDA
Pipeline program

docetaxel and ketoconazole

BR01/07/05

Phase 2 small_molecule completed

Quick answer

docetaxel and ketoconazole for Metastatic Breast Cancer is a Phase 2 program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Metastatic Breast Cancer
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials